Legumes and soybeans: Overview of their nutritional profiles and health effects

American Journal of Clinical Nutrition

Volumn 70, Issue 3 SUPPL., 1999, Pages

  Messina, Mark J ^a  

^a Nutrition Matters Inc   (United States)

Author keywords

Beans; Breast cancer; Cancer prevention; Dietary fiber; Genistein; Isoflavones; Legumes; Osteoporosis prevention; Phytochemicals; Prostate cancer; Soybeans; Soyfoods

Indexed keywords

ISOFLAVONE; ISOFLAVONE DERIVATIVE; TRACE ELEMENT;

BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER MORTALITY; CHEMICAL STRUCTURE; CONFERENCE PAPER; DIET; ESTROGEN ACTIVITY; HEALTH FOOD; HIGH RISK POPULATION; HUMAN; LEGUME; NUTRITIONAL STATUS; NUTRITIONAL VALUE; OSTEOPOROSIS; RISK FACTOR; SOYBEAN;

GLYCINE MAX; RODENTIA;

EID: 0032839807     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.3.439s     Document Type: Conference Paper

References (188)

1. Hellendoorn EW. Beneficial physiologic action of beans. J Am Diet Assoc 1976;69:248-53.
2. Committee on Diet and Health, National Research Council. Diet and health: implications for reducing chronic disease risk. Washington, DC: National Academy Press, 1989.
3. Life Sciences Research Office, Federation of American Societies for Experimental Biology. Third report on nutrition monitoring in the United States. Vol 1. Washington, DC: US Government Printing Office, 1995.
4. Commercial Agricultural Division, Economic Research Service, US Department of Agriculture. Dry edible beans: US per capita use for selected classes, 1970-1997. Washington, DC: US Government Printing Office, 1997.
5. US Department of Agriculture. The food guide pyramid. Hyattsville, MD: Human Nutrition Information Service, 1992. (Publication HG252.)
6. Donovan UM, Gibson RS. Dietary intakes of adolescent females consuming vegetarian, semi-vegetarian, and omnivorous diets. J Adolesc Health 1996;18:292-300.
7. Ridout CL, Wharf G, Price KR, Johnson LT, Fenwick GR. UK mean daily intakes of saponins - intestine-permeabilizing factors in legumes. Food Sci Nutr 1988;42F:111-6.
8. Whitten C, Haddad E, Sabaté J. Developing a vegetarian food guide pyramid: a conceptual framework. Vegetarian Nutr 1997;1:25-9.
9. Sabaté J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 1999(suppl);70:500S-3S.
10. Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr 1999(suppl):70:504S-11S.
11. Kushi LH, Meyer KA, Jacobs DR Jr. Cereals, legumes, and chronic disease risk: evidence from epidemiologic studies. Am J Clin Nutr 1999;70(suppl):451S-8S.
12. Anderson JW, Smith BS, Washnock CS. Cardiovascular and renal benefits of dry beans and soybean intake. Am J Clin Nutr 1999(suppl):70:464S-74S.
13. Pennington, JAT. Bowes and Churches food values of portions commonly used. 16th ed. Philadelphia: JB Lippincott, 1994.
14. Consumer and Food Economic Institute. Composition of foods: raw, processed, and prepared. Agriculture handbook no. 8. Washington, DC: US Government Printing Office, 1976.
15. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
16. Sarwar G, Peace RW, Botting HG, Brule D. Relationship between amino acid scores and protein quality indices based on rat growth. Plant Foods Hum Nutr 1989;39:33-44.
17. Sarwar G, Peace RW, Botting HG. Corrected relative net protein ratio (CRNPR) method based on differences in rat and human requirements for sulfur amino acids. J Am Oil Chem Soc 1985;68:689-93.
18. Food and Drug Administration, Department of Health and Human Services. Food labeling: general requirements for health claims for food. Fed Regist 1991;56:60537-66.
19. Sarwar G, McDonough FE. Evaluation of protein digestibility-corrected amino acid score method for assessing protein quality of foods. J Assoc Off Anal Chem 1990;73:347-56.
20. Sarwar G. The protein digestibility-corrected amino acid score method overestimates quality of proteins containing antinutritional factors and of poorly digestible proteins supplemented with limiting amino acids in rats. J Nutr 1997;127:758-64.
21. Chan JCM. The influence of dietary intake on endogenous acid production. Nutr Metab 1974;16:1-9.
22. Remer T, Manz F. Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr 1994;59:1356-61.
23. Kerstetter JE, Allen LH. Dietary protein increases urinary calcium. J Nutr 1989;120:134-6.
24. Anderson JJB, Thomsen K, Christiansen, C. High protein meals, insular hormones and urinary calcium excretion in human subjects. In: Christiansen C, Johansen JS, Riis BJ, eds. Osteoporosis. Viborg, Denmark: Nørhaven A/S, 1987:240-5.
25. Breslau NA, Brinkley L, Hill KD, Pack CYC. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988;66;140-6.
26. Kerstetter JE, O'Brien KO, Insogna KL. Dietary protein influences intestinal calcium absorption. Am J Clin Nutr 1997;66:215 (abstract 70).
27. Pannemans DLE, Schaafsma G, Westerterp KR. Calcium excretion, apparent calcium absorption and calcium balance in young and elderly subjects: influence of protein intake. Br J Nutr 1997;77:721-9.
28. US Department of Agriculture, Nutrient Data Research Branch, Nutrition Monitoring Division. Provisional table on the content of omega-3 fatty acids and other fat components in selected foods. Hyattsville, MD: Human Nutrition Information Service, 1988. (Publication HNIS/PT-103.)
29. Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 1997;127:383-93.
30. Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Am J Clin Nutr 1997;65:1083-6.
31. Caygill CPJ, Charlett A, Hill MJ. Fat, fish, fish oil and cancer. Br J Cancer 1996;74:159-64.
32. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70(suppl):560S-9S.
33. Oski FA. What we eat may determine who we can be. Nutrition 1997;13:220-1.
34. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994; 1213:277-88.
35. Indu M, Ghafoorunissa. N-3 fatty acids in Indian diets - comparison of the effects of precursor (alpha-linolenic acid) vs product (long chain n-3 polyunsaturated fatty acids). Nutr Res 1992;12:569-82.
36. Messina M, Messina V. The dietitian's guide to vegetarian diets: issues and applications. Rockville, MD: Aspen Publishers, 1996:443-4.
37. WHO and FAO joint consultation: fats and oils in human nutrition. Nutr Rev 1995;53:202-5.
38. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. JAMA 1995;274:1698-702.
39. Lynch SR, Beard JL, Dassenko SA, Cook JD. Iron absorption from legumes in humans. Am J Clin Nutr 1984;40:42-7.
40. Monsen ER, Hallberg L, Layrisse M, et al. Estimation of available dietary iron. Am J Clin Nutr 1978;31:134-41.
41. Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. Am J Clin Nutr 1994;59:1381-5.
42. Cook JD, Dassenko SA, Lynch SR. Assessment of the role of non-heme-iron availability in iron balance. Am J Clin Nutr 1991;54: 717-22.
43. Sandström B, Almgren A, Kivistö B, Cederblad A. Effect of protein level and protein source on zinc absorption in humans. J Nutr 1989;119:48-53.
44. Weaver CM, Heaney RP, Proulz WR, Hinders SM, Packard PT. Absorbability of calcium from common beans. J Food Sci 1993;58: 1401-3.
45. Weaver CM, Plawecki KL. Dietary calcium: adequacy of a vegetarian diet. Am J Clin Nutr 1994;59(suppl):1238S-41S.
46. Marlett JA. Content and composition of dietary fiber in 117 frequently consumed foods. J Am Diet Assoc 1992;92:175-86.
47. Anderson JW, Story L, Sieling B, Chen W-JL. Hypocholesterolemic effects of high-fibre diets rich in water-soluble plant fibres. J Can Diet Assoc 1984;47:140-8.
48. Jenkins DJA, Wolever TMS, Taylor RH, Barker HM, Fielden H. Exceptionally low blood glucose response to dried beans: comparison with other carbohydrate rich foods. Br Med J 1980;281:578-80.
49. Foster-Powell K, Miller JB. International tables of glycemic index. Am J Clin Nutr 1995(suppl);62:871S-90S.
50. Thorne MJ, Thompson LU, Jenkins DJ. Factors affecting starch digestibility and the glycemic response with special reference to legumes. Am J Clin Nutr 1983;38:481-8.
51. Thompson LU, Yoon JH, Jenkins DJ, Wolever TM, Jenkins AL. Relationship between polyphenol intake and blood glucose response of normal and diabetic individuals. Am J Clin Nutr 1984;39:745-51.
52. Yoon JH, Thompson LU, Jenkins DJ. The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response. Am J Clin Nutr 1983;38:835-42.
53. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 1994;17:519-22.
54. Wolever TMS. The glycemic index: flogging a dead horse? Diabetes Care 1997;20:452-56.
55. Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willet WC. Dietary fiber, glycemic load, and risk of non-insulin dependent diabetes mellitus in women. JAMA 1997;277:472-7.
56. Grant G. Anti-nutritional factors of soybean: a review. Prog Food Nutr Sci 1989;13:317-48.
57. Duarte-Rayas P, Bergeron D, Nielsen SS. Screening of heat-stable trypsin inhibitors in dry beans and their partial purification from great Northern beans (Phaseolus vulgaris) using anhydrotrypsin-sepharose affinity chromatography. J Agric Food Chem 1992;40:32-42.
58. Liener IE. Implications of antinutritional components in soybean foods. Crit Rev Food Sci Nutr 1994;34:31-67.
59. Kennedy AR, Manzone H. Effects of protease inhibitors on levels of proteolytic activity in normal and premalignant cells and tissues. J Cell Biochem 1995;22(suppl):188-94.
60. Oberleas D, Harland BE. Phytate content of foods: effect on dietary zinc bioavailability. J Am Diet Assoc 1981;79:433-6.
61. Mage JA. Phytate: its chemistry, occurrence, food interactions, nutritional significance, and methods of analysis. J Agric Food Chem 1982;30:1-9.
62. Graf E, Eaton JW. Antioxidant functions of phytic acid. Free Radic Biol Med 1990;8:61-9.
63. Harland BF, Morris ER. Phytate: a good or a bad food component? Nutr Res 1995;15:733-54.
64. Vucenik I, Yang G-Y, Shamsuddin AM. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer 1997;28:7-13.
65. Steggerda FR, Dimmick JF. Effects of bean diets on concentration of carbon dioxide in flatus. Am J Clin Nutr 1966;19:120-4.
66. Rackis JJ, Sessa DJ, Steggerda FR, Shimizu T, Anderson T, Pearl SL. Soybean factors relating to gas production by intestinal bacteria. J Food Sci 1970;35:634-9.
67. Carlsson N-G, Karlsson H, Sandberg A-S. Determination of oligosaccharides in foods, diets, and intestinal contents by high-temperature gas chromatography and gas chromatography/mass spectrometry. J Agric Food Chem 1992;40;2404-12.
68. Kuo TM, VanMiddlesworth JF, Wolf WJ. Content of raffinose oligosaccharides and sucrose in various plant seeds. J Agric Food Chem 1988;36:32-6.
69. Anderson RL, Rackis JJ, Tallent WH. Biologically active substances in soy products. In: Wilcke HL, Hopkins DT, Waggle DH, eds. Soy protein and human nutrition. New York: Academic Press, 1979.
70. Mitsuoka T. Recent trends in research on intestinal flora. Bifidobacteria Microflora 1982;1:3-24.
71. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 1989;55:1100-5.
72. Koo M, Rao AV. Long term effect of bifidobactaria and neosugar on precursor lesions. Nutr Cancer 1991;16:249-57.
73. Hata Y, Yamamoto M, Nakajima K. Effects of soybean oligosaccharides on human digestive organs: estimate of fifty percent effective dose and maximum non-effective dose based on diarrhea. J Clin Biochem Nutr 1991;10:135-44.
74. Slavin JL, Martini MC, Jacobs DR Jr, Marquart L. Plausible mechanisms for protectiveness of whole grains. Am J Clin Nutr 1999(suppl);70:459S-63S.
75. Milgate J, Roberts DCK. The nutritional and biological significance of saponins. Nutr Res 1995;15:1223-49.
76. Koratkar R, Rao AV. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr Cancer 1997;27:206-9.
77. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
78. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
79. Wang H-J, Murphy PA. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location. J Agric Food Chem 1994;42:1674-7.
80. Joannou GE, Kelly GE, Reeder AY, Waring M, Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995;54:167-84.
81. Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40:569-78.
82. Kelly GE, Joannu GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavone in humans. Proc Soc Exp Biol Med 1995;208:40-50.
83. Bradbury RB, White DE. Oestrogens and related substances in plants. Vitam Horm 1954;12:207-12.
84. Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 1966;34:215-25.
85. Geynet C, Millet C, Truong H, Baulieu EE. Estrogens and antiestrogens. Hormone antagonists. Gynecol Invest 1972;3:2-29.
86. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978;103:1860-7.
87. Biggers JD, Curnow DH. Oestrogenic activity of subterranean clover. Biochem J 1954;58:278-82.
88. Bickoff EM, Livingston AL, Hendrickson AP, Booth AN. Relative potencies of several estrogen-like compounds found in forages. J Agric Food Chem 1962;10:410-2.
89. Mayr U, Butsch A, Schneider S. Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 1992;74;135-49.
90. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993;45:399-405.
91. Xu X, Harris KS, Wang H-J, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995;125:2307-15.
92. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342:1209-10.
93. Mäkela SI, Pylkkänen LH, Santti RSS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nutr 1995;125:437-45.
94. Adlercreutz H, Mazur W. Phyto-oestrogens and western diseases. Ann Med 1997;29:95-120.
95. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalmic/pituitary axis in rats. J Nutr 1997;127:263-9.
96. Dodge JA, Glasebrook AL, Magee DE, et al. Environmental estrogens: effects on cholesterol lowering and bone in ovariectomized rat. J Steroid Biochem Mol Biol 1996;59:155-61.
97. Markaverich BM, Webb B, Densmore CL, Gregory RR. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ Health Perspect 1995;103:574-81.
98. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-7.
99. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50.
100. Jayo MJ, Anthony MS, Register TC, Rankin SE, Vest T, Clarkson TB. Dietary soy isoflavones and bone loss in ovariectomized monkeys. FASEB J 1997;11:S228 (abstr).
101. Collins BM, McLachlan JA, Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997;62:365-72.
102. Loukovaara M, Carson M, Palotie A, Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 1995;60:656-61.
103. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
104. Cassidy A, Bingham S, Setchell KD. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br J Nutr 1995;74:587-601.
105. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
106. Wang TTY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996;17:271-5.
107. McDonnell DP, Norris JD. Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone. Osteoporos Int 1997;7(suppl):S29-34.
108. Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997;138:863-70.
109. Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1991;135:130-41.
110. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast fluid secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94.
111. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in histologically normal human breasts. Am J Clin Nutr 1998;68(suppl):1431S-6S.
112. Messina M, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21:113-31.
113. Messina MJ, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991;83:541-6.
114. Jing Y, Nakaya K, Han R. Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo. Anticancer Res 1993;13:1049-54.
115. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991; 179:661-7.
116. Peterson G, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 1996;7:1345-51.
117. Pagliacci MC, Smacchia M, Migliorati G, Grignana F, Riccardi C, Nicoletti I. Growth-inhibitory effects of the natural phytoestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 1994; 30A:1675-82.
118. Peterson G, Coward L, Kirk M, Falany C, Barnes S. The role of metabolism in mammary epithelial growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis 1996;17:1861-9.
119. So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK. Inhibition of human breast cell proliferation by flavonoids and citrus juice. Nutr Cancer 1996;26:167-81.
120. Clark JW, Santos-Moore A, Stevenson LE, Frackelton AR. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer lines and proteins important in the RAS signaling pathway. Int J Cancer 1996;65:186-91.
121. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997;27:31-40.
122. Peterson G, Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor autophosphorylation. Prostate 1993;22:335-45.
123. Naik HR, Lehr JE, Pienta KJ. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res 1994;14:2617-20.
124. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997;51: 193-200.
125. Kuo S-M, Morehouse HF Jr, Lin C-P. Effect of antiproliferative flavonoids on ascorbic acid accumulation in human colon adenocarcinoma cells. Cancer Lett 1997;116:131-7.
126. Kuo S-M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996;110:41-8.
127. Rauth S, Kichina J, Green A. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. Br J Cancer 1997;75: 1559-66.
128. Akiyama T, Ogawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991;201:362-70.
129. Constantinou A. Huberman E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 1995;208:109-15.
130. Scholar EM, Toewa ML. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett 1994;87:159-62.
131. Santibáñez JF, Navarro A, Martinez J. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 1997;17:1199-1204.
132. Wei H, Wei L, Frenkel K, Bowen R, Barnes S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 1993;20:1-12.
133. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262:5592-5.
134. Thorburn J, Thorburn T. The tyrosine kinase inhibitor, genistein, prevents α-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway. Biochem Biophys Res Commun 1994;202:1586-91.
135. Linassier C, Pierre M, Le Peco J-B, Pierre J. Mechanism of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 1990;39:187-93.
136. Constantinou A, Kiguchi K, Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 1990;50:2618-24.
137. Peterson TG, Kim H, Barnes S. Genistein may inhibit the growth of human mammary epithelial (HME) cells by augmenting transforming growth factor beta (TGFβ) signaling. Am J Clin Nutr 1998; 68(suppl):1527S (abstr).
138. Benson JR, Colletta AA. Transforming growth factor β. Prospects for cancer prevention and treatment. Clin Immunother 1995;4:249-58.
139. Benson JR, Baum M, Colletta AA. Role of TGFβ in the anti-estrogen response/resistance of human breast cancer. J Mammary Gland Biol Neoplasia 1996;1:381-9.
140. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 1997;7:93-102.
141. Cancer facts and figures. Atlanta: American Cancer Society, 1994.
142. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza MW, Aeschbacher H-U, Felton JS, Sato S, eds. Mutagens and carcinogens in the diet. New York: Wiley Liss, 1990:239-53.
143. Lee HP, Gourley L, Duffy SW, Esteve J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991;337:1197-200.
144. Hirose K, Tajima K, Hamajima N, et al. A large-scale, hospital-based case-control study of risk factors of breast cancers according to menopausal status. Jpn J Cancer Res 1995;86:146-54.
145. Yuan J-M, Wang Q-S, Ross RK, Henderson BE, Yu MC. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 1995;71: 1353-8.
146. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996;5:901-6.
147. Greenstein J, Kushi L, Zheng W, et al. Risk of breast cancer associated with intake of specific foods and food groups. Am J Epidemiol 1996;145:S36 (abstr).
148. Peterson G, Barnes S. Genistein potently inhibits the growth of human primary breast epithelial cells: correlation with lack of genistein metabolism. Mol Biol Cell 1994;5:384a (abstr).
149. Constantinou AL, Mehta RG, Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 1996;16:3293-8.
150. Evans BAJ, Griffiths K, Morton MS. Inhibition of 5″-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.
151. Franke AA, Mordan LJ, Conney RV, et al. Dietary phenolic agents inhibit neoplastic transformation and trap toxic NO. Proc Am Assoc Cancer Res 1995;36:125 (abstr).
152. Brown NM, Lamartiniere CA. Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect 1995;103:708-13.
153. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 1995;16:2833-40.
154. Murrill WB, Brown NM, Zhang J-X, et al. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996;17:1451-7.
155. Yatani R, Kusano I, Shiraishi T, Hayashi T, Stemmerman GN. Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn J Clin Oncol 1989;19:319-26.
156. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993;118:793-803.
157. Ross RK, Bernstein LA, Lobo RA, et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992;339:887-9.
158. Lu L-J, Anderson KE, Nagamani M. Effects of one month soya consumption on circulating steroids in men. Proc Am Assoc Cancer Res 1996;37:270 (abstr).
159. Pollard M, Luckert PH. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 1997;28:41-5.
160. Zhang JX, Hallmans G, Landström M, et al. Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett 1997;114:313-4.
161. Schleicher R, Zheng M, Zhang M, Lamartiniere CA. Genistein inhibition of prostate cancer cell growth and metastasis in vivo. Am J Clin Nutr 1998;68(suppl):1526S(abstr).
162. Dalu A, Haskell J, Lamartiniere CA. Dietary genistein inhibits protein tyrosine phosphorylation in the dorsolateral prostate of the rat. Am J Clin Nutr 1998;68(suppl):1524S(abstr).
163. Geller J, Sionit L, Partido C, et al. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 1998;34:75-9.
164. Severson KJ, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-60.
165. Morton MS, Matos-Ferreira A, Abranches-Monteiro L, et al. Measurement and metabolism of isoflavonoids and lignans in human male. Cancer Lett 1997;114:145-51.
166. Stephens FO. Phytoestrogens and prostate cancer: possible preventive role. Med J Aust 1997;167:138-40.
167. Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 1993; 90:2690-4.
168. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235; 442-7.
169. McAllister KA, Baldwin MA, Thukkani AK, et al. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995;4:1983-5.
170. Valente M, Bufalino L, Castiglione GN, et al. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 1994;54:377-80.
171. Brandi ML. Flavonoids: biochemical effects and therapeutic applications. Bone Miner 1992;19(suppl):S3-64.
172. Tsuda M, Kitazaki T, Ito T, Fujita T. The effect of ipriflavone (TC-80) on bone resorption in tissue culture. J Bone Miner Res 1986;1:207-11.
173. Ross PD, Norimatsu H, Davis JW, et al. A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 1991;133:801-9.
174. Fujita T, Fukase M. Comparison of osteoporosis and calcium intake between Japan and the United States. Proc Soc Exp Biol Med 1992; 200:149-52.
175. Kin K, Lee JH, Kushida K, et al. Bone density and body composition on the Pacific Rim: a comparison between Japan-born and U.S.-born Japanese-American women. J Bone Miner Res 1993;8:861-9.
176. Ross PD, Fujiwara S, Huang C, et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol 1995;24:1171-7.
177. Russell-Aulet M, Wang J, Thornton JC, Colt EW, Pierson RN Jr. Bone mineral density and mass in a cross-sectional study of white and Asian women. J Bone Miner Res 1993;8:575-82.
178. Nakamura T, Turner CH, Yoshikawa T, et al. Do variations in hip geometry explain differences between Japanese and white Americans? J Bone Miner Res 1994;9:1071-6.
179. Davis JW, Ross PD, Nevitt MC, Wasnich RD. Incidence rates of falls among Japanese men and women living in Hawaii. J Clin Epidemiol 1997;50:589-94.
180. Anderson JJ, Ambrose WW. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomized rat models. J Nutr 1995;125(suppl):799S (abstr).
181. Arjmandi BH, Birnbaum R, Goyal NV, et al. Bone-sparing effect of soy protein in ovarian-hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 1998;68(suppl):1364S-8S.
182. Blair HC, Jordon SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996;61:629-37.
183. Fanti O, Faugere MC, Gang Z, Schmidt J, Cohen D, Malluche HH. Systemic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism. Am J Clin Nutr 1998;68(suppl):1517S (abstr).
184. Arjmandi BH, Getlinger MJ, Goyal NV, et al. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998;68(suppl):1358S-63S.
185. Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density. JAMA 1997;277:543-7.
186. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(suppl): 1375S-9S.
187. Dalais FS, Rice GE, Bell RJ, et al. Dietary soy supplementation increases vaginal cytology maturation index and bone mineral content in postmenopausal women. Am J Clin Nutr 1998;68(suppl): 1518S (abstr).
188. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 1996;2:1132-6.